Business Case

Characterized potential adoption challenges for a developmental allergic conjunctivitis product to facilitate strategic commercialization planning at a mid-sized ophthalmology company

A mid-sized ophthalmology company was developing a strategy to launch in Allergic Conjunctivitis and needed to understand the current market and implications of various payer formulary placements on the market potential. LSC mapped potential hurdles to adoption, determined the market share (with comparison to competitors), and various commercialization scenario. Based on these analyses, LSC was able to develop a full P&L and proceed into tactical launch planning activities.